Alcon (ALC) DIvidends Date & History

Key Takeaways

• Alcon Inc. (ALC) offers a low current dividend yield of approximately 0.33% with an annual dividend of $0.23 per share.
• The company pays dividends annually and has increased its dividend for four consecutive years since initiating payments in 2021.
• Payout ratio stands at a conservative 13.96%, indicating strong earnings coverage and dividend sustainability.
• Robust free cash flow, exceeding $1.6 billion annually, supports ongoing dividend payments and potential future growth.
• Yield is below the healthcare sector average, positioning ALC as a dividend growth candidate rather than a high-income stock.
• Financial stability and low payout make the dividend attractive for long-term investors focused on sustainability.

Dividend Overview

Alcon Inc. (ALC), a leading eye care company, maintains a modest dividend policy focused on sustainable growth rather than high yields. The current annual dividend is $0.23 per share, resulting in a yield of about 0.33%. Dividends are paid once per year, with the most recent ex-dividend date on May 6, 2026. This profile classifies ALC as a dividend growth stock with a conservative approach, appealing to investors seeking stability over immediate high income.

Dividend History and Growth

Alcon began paying dividends in 2021 and has maintained a consistent annual schedule with four years of increases. The dividend has grown steadily, reflecting a long-term strategy of returning capital to shareholders while investing in business expansion. No cuts have occurred, underscoring reliability amid the company's post-spin-off maturation as an independent public entity.

Dividend Sustainability and Payout Ratio

The low payout ratio of 13.96% demonstrates excellent earnings coverage, leaving ample room for reinvestment and future dividend hikes. Strong free cash flow generation, reaching $1.6 billion in recent annual figures, further bolsters sustainability. Low debt levels and positive cash flow trends support the dividend's resilience, even in varying economic conditions.

Dividend Compared to Industry Peers

Alcon Inc. (ALC)'s yield of 0.33% is notably lower than the healthcare sector average of around 2.1%. Peers in medical equipment and devices often offer higher yields but may carry elevated payout ratios. ALC stands out for its conservative profile, prioritizing growth and coverage over yield maximization.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.

Is This Stock Attractive for Dividend Investors?

Alcon Inc. (ALC) may suit dividend growth investors and long-term holders who prioritize sustainability and modest income over high current yields. Its low payout ratio and strong free cash flow provide a buffer for consistent payments and potential increases. Conservative investors seeking exposure to the healthcare sector with lower risk of dividend cuts could find value here. Income-focused investors might prefer higher-yielding alternatives, while those building a diversified portfolio for capital appreciation alongside dividends may consider the stock's balanced profile.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations